Michael Lattanzi
7PUBLICATIONS
45CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jun 16, 2025
Quality of Informed Consent via Telemedicine Compared With In-Person for Clinical Cancer Research.Michal Sternschuss, Michael Lattanzi, Emily Vertosick
|Sep 08, 2023
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience.Brendan J Guercio, Michal Sarfaty, Min Yuen Teo
|Jan 28, 2022
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial.Samuel A Funt, Michael Lattanzi, Karissa Whiting
|Jun 20, 2020
The emerging role of antibody-drug conjugates in urothelial carcinoma.Michael Lattanzi, Jonathan E Rosenberg
|Nov 09, 2019
Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma.Anna Pavlick, Ana B Blazquez, Marcia Meseck
|May 19, 2018
Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis.Michael Lattanzi, Joseph Han, Una Moran
Pageof 2
Frequent Collaborators
4 joint publications
Jonathan E Rosenberg
4 joint publications
Samuel A Funt
3 joint publications
Gopa Iyer
3 joint publications
Ashley Regazzi
2 joint publications
Bernard H Bochner
2 joint publications
Dean F Bajorin
2 joint publications
Hikmat Al-Ahmadie
2 joint publications
Min Yuen Teo
2 joint publications
Chung-Han Lee
2 joint publications
Eugene Pietzak
